Opinion

Video

Closing Thoughts From The Panel On Pneumococcal Vaccination

Author(s):

Christina M. Madison, PharmD, FCCP, AAHIVP,Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP

The panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.

Related Videos
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Senior Doctor is examining An Asian patient.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
3 KOLs are featured in this series.
Related Content
Pneumococcal vaccine in a vial, immunization and treatment of infection
November 9th 2024

Providers Prefer Increased Pneumonia, IPD Coverage and Lower Age Recommendation For Pneumococcal Vaccines

Luke Halpern, Assistant Editor
Streptococcus pneumoniae bacteria, 3D scientific illustration
November 6th 2024

Cigarette Smoke Hinders Innate Immune Response to Pneumococcal Infection

Luke Halpern, Assistant Editor
Pneumonia. Pneumococcal, Immunization | Image Credit: mi_viri - stock.adobe.com
October 24th 2024

ACIP Lowers Pneumococcal Vaccination Recommendation to Age 50

Ashley Gallagher, Associate Editor
Vial with pneumococcal disease vaccine and syringe for injection.
October 21st 2024

Pneumococcal 21-Valent Conjugate Vaccine Generates Positive Response in Adults at Increased Risk of Disease

Luke Halpern, Assistant Editor
Vial of pneumococcal vaccine.
July 2nd 2024

ACIP Votes to Recommend Pneumococcal 21-Valent Conjugate Vaccine for Adult Populations

Luke Halpern, Assistant Editor
Pneumococcal vaccine | Image Credit: Iryna - stock.adobe.com
June 18th 2024

FDA Approves V116 for Prevention of Invasive Pneumococcal Disease and Pneumonia

Ashley Gallagher, Associate Editor